Longitudinal Changes of [18F]PI-2620 Positron Emission Tomography in Subjects With Cognitively Normal, Mild Cognitive Impairment and Alzheimer's Disease

NCT03903211 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Cognitively Normal
Mild Cognitive Impairment
Alzheimer Disease

Interventions

DRUG: [18F]PI-2620

Sponsor

Jae Seung Kim